Dr Reddys Laboratories (RDY) EPS (Diluted) (2009 - 2026)
Dr Reddys Laboratories' EPS (Diluted) was $0.16 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 33.8% from $0.24 a year earlier but up 183.3% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Dr Reddys Laboratories' EPS (Diluted) was $0.44 through Sep 30, 2026, down 54.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $0.58, down 26.7% from FY2025.
- EPS (Diluted) shows a five-year compound annual growth rate of 8.2% (FY2021 to FY2026).
- In earlier fiscal years, EPS (Diluted) was $0.79 in FY2025 (-1.5%), $0.81 in FY2024 (+19.5%), $0.68 in FY2023 (+41.9%) and $0.48 in FY2022 (+21.1%).
- Quarterly EPS (Diluted) has moved between $0.02 (fiscal Q4 2022) and $0.27 (fiscal Q3 2025) over five years.
- Compared with a year earlier, EPS (Diluted) has declined for six straight quarters, with an average decline of 25.9% over the last eight quarters.
- The best year-over-year quarter for EPS (Diluted) over five years was fiscal Q4 2023 (growth of 645.3%); the worst was fiscal Q4 2026 (a decline of 88.2%).
- Per Business Quant data, RDY's EPS (Diluted) in the three fiscal quarters before Q2 2027 was $0.06 (Q1 2027), $0.03 (Q4 2026) and $0.19 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 0.56 |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 0.16 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.16 |
| Jun 30, 2026 | 0.06 |
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.22 |
| Dec 31, 2023 | 0.25 |
| Sep 30, 2023 | 0.22 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.94 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.15 |
API Access
Dr Reddys Laboratories EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();